Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
4.010
+0.080 (2.04%)
At close: Mar 6, 2026, 4:00 PM EST
4.040
+0.030 (0.75%)
After-hours: Mar 6, 2026, 7:59 PM EST
Prime Medicine Employees
Prime Medicine had 214 employees as of December 31, 2024. The number of employees decreased by 20 or -8.55% compared to the previous year.
Employees
214
Change (1Y)
-20
Growth (1Y)
-8.55%
Revenue / Employee
$21,645
Profits / Employee
-$939,916
Market Cap
710.09M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 214 | -20 | -8.55% |
| Dec 31, 2023 | 234 | 59 | 33.71% |
| Dec 31, 2022 | 175 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Gyre Therapeutics | 579 |
| Replimune Group | 479 |
| ProKidney | 204 |
| Lexicon Pharmaceuticals | 103 |
| Annexon | 99 |
| Theravance Biopharma | 97 |
| Tectonic Therapeutic | 60 |
PRME News
- 1 day ago - Prime Medicine, Inc. (PRME) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 4 days ago - Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 10 days ago - Prime Medicine to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - Prime Medicine, Inc. (PRME) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Prime Medicine to Present at 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Prime: Maintaining 'Buy' On Solidified Catalysts For Wilson's Disease And Beyond - Seeking Alpha
- 3 months ago - Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease - GlobeNewsWire
- 3 months ago - Prime Medicine to Present at 8th Annual Evercore Healthcare Conference - GlobeNewsWire